Marilyn Dammerman

Common genetic variation in the promoter of the human apo CIII gene abolishes regulation by insulin and may contribute to hypertriglyceridemia.

W W Li, Marilyn Dammerman, Jonathan D. Smith et al. · Journal of Clinical Investigation · 1995 · 276 citations · Full text

An apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and 3' untranslated region polymorphisms.

Marilyn Dammerman, Lodewijk A. Sandkuijl, Jeffrey L. Halaas et al. · Proceedings of the National Academy of Sciences · 1993 · 227 citations · Full text

Genetics, Human Polymorphism, Pathology +19

Absence of Mutations in the Human <i>OB</i> Gene in Obese/Diabetic Subjects

Margherita Maffei, Markus Stoffel, Marisa Barone et al. · Diabetes · 1996 · 165 citations · Full text

Metabolic Disorder, Genetics, Genetic Epidemiology +20

Localization and characterization of the binding site for the regulatory subunit of type II cAMP-dependent protein kinase on MAP2

Heidi M. Rubino, Marilyn Dammerman, Bridget Shafit‐Zagardo et al. · Neuron · 1989 · 128 citations

Regulatory Subunit, Molecular Physiology, Signal Transduction +12

A monoclonal antibody equivalent to anti-rat neural antigen-1 as a marker for schwann cells

Kay L. Fields, Marilyn Dammerman · Neuroscience · 1985 · 65 citations

Anti-rat Neural Antigen-1, Neuroregeneration, Laboratory Immunology +13